VIVIMEDLAB closed at ₹6.58 on Sep 4, 2026. Vivimed Labs Limited (VIVIMEDLAB) trades on NSE/BSE. Market capitalisation is ₹54.56 Cr. It operates in the Healthcare sector.
VIVIMEDLAB, by the numbers
Vivimed Labs Limited (NSE: VIVIMEDLAB), read straight from exchange filings and end-of-day market data where it exists. Below: the signal layers and the numbers behind them, each marked with its source.
1D+0.6%
1W−6.9%
1M+27.0%
3M+3.0%
6M−7.5%
1Y+32.9%
3Y+32.9%
5Y−69.2%
Revenue YoY-53.15%Q4'26 · -24.95% QoQ
PAT YoY—loss-making — see filings
EPS (TTM)₹-20.16
ROE—loss-making period
ROCE—loss-making period
P/E—loss-making period
P/B—not meaningful — negative equity
Div yield0%none in last 12 months
Avg volume86,24020-session median
Delivery %—of traded qty
Beta—needs NIFTY 50
Market cap₹54.56 CrMicro cap
Technical postureEOD derived
20-DMA ₹650-DMA ₹6200-DMA ₹7RSI 63.6ATR 3.6%
Supports ₹6 · ₹6 · ₹6Resistances ₹7 · ₹7 · ₹7
What the data showsauto-derived from filings + price · refreshed nightly
▲ Working for it — from the filings
No standout strengths in the current filings.
▼ Worth watching
Loss-makingon the latest annual filing
Muted salesrevenue -53.15% YoY on the latest quarter
Not built yetAI synthesis — not built yetOne paragraph that fuses VIVIMEDLAB's latest filings with its price structure. Not built yet — nothing behind this card generates it today.
Vivimed Labs Ltd - 532660 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsAug 17, 2026 · BSE · raw filing ↗
About & managementfrom filings & exchange disclosures
Vivimed Labs Limited is a micro-cap healthcare company traded on the NSE and BSE.
Coming soon
Company facts (founded, HQ, employees) and the board / KMP roster with tenures arrive with the company-profile source.
Past EOD returns redistributed — not a projection. LTCG shown at 12.5% beyond the ₹1.25 L/yr exemption (FY26 rules), indicative only, not tax advice; SIP units have mixed holding periods.
Frequently asked
auto-built per stock · FAQ schema
Once VIVIMEDLAB's end-of-day history is ingested, this page shows its official exchange close, refreshed after each trading session, with the full price history on the Chart tab (split- and bonus-adjusted for NSE-primary series; BSE-primary series are shown as-traded). Upmazing does not stream live quotes, so every price-linked figure is anchored to the last close.
Where enough filed data exists, VIVIMEDLAB carries an Upmazing Score, a 0-100 standing computed from its real fundamentals (growth, margins, leverage, returns) and end-of-day technicals. The Score tab breaks down every component, and says plainly when one can't be computed.
After each session with price data on record, VIVIMEDLAB runs through Upmazing's end-of-day scanner library, covering momentum, trend, volatility, volume and fundamental checks. Scanners that fired on the latest session are listed on the Patterns tab with the exact rule each fired on.
Declared dividends, ex-dates and bonus or split history for VIVIMEDLAB come from corporate-action records and appear here as they are ingested. Dividend yield is computed on trailing-12-month dividends at the last close.
Comparable companies for VIVIMEDLAB are grouped by sector, then compared on revenue growth, ROE, ROCE, debt-to-equity and margins. The Peers tab shows the full side-by-side table, and where a sector is classified, the sector peers panel on this page links the largest sector-mates.
Market cap for VIVIMEDLAB is computed from shares outstanding in the filed balance sheet, priced at the last close, and refreshed after each session. Where the balance-sheet input or a last close is missing, the cell shows a dash rather than an estimate.
The trailing 52-week high and low for VIVIMEDLAB are derived from its end-of-day price history and appear in the key statistics on this page once a full year of sessions is on record. The full price chart lives on the Chart tab.
The filed balance sheet for VIVIMEDLAB is presented on the Financials tab; for non-lenders that includes debt-to-equity, while banks and NBFCs read leverage through banking ratios instead.
Where VIVIMEDLAB's shareholding pattern has been ingested, the Holdings tab tracks promoter, FII, mutual-fund, DII and public holding plus any promoter pledge, quarter by quarter from the disclosed filings.
Prices are official exchange end-of-day closes, refreshed after each trading session. Fundamentals, shareholding and corporate actions for VIVIMEDLAB are parsed from official filings — quarterly results, shareholding disclosures and corporate-action records — as they are published.
Filed results · consolidated · audited·as of Q4 2025-26partial data
Frequently Asked Questions
What is Vivimed Labs Limited's share price today?
Vivimed Labs Limited (VIVIMEDLAB) closed at ₹6.58 on 2026-09-04.
Which sector does Vivimed Labs Limited belong to?
Vivimed Labs Limited is classified under sector 'Healthcare' / industry 'Pharmaceuticals & Biotechnology' per NSE's 4-tier classification.